Assessment of Dyslipidemic Patients' Knowledge, Quality of Life, and Adherence

Al-Rasheed University College

Status: Completed

Conditions: Dyslipidemias

Treatments: Behavioral: Pharmaceutical care plan

Study type: Interventional

Funder types: Other

Identifiers

NCT04319029

AR190101

Details and patient eligibility

About

A randomized, parallel two-arm interventional study, the patients were divided into 1:1 ratio, in which both groups offered optimal pharmacological therapy also one group (interventional) offered predesign pharmaceutical care plan aimed to improved patients knowledge, adherence, satisfaction, and quality of life, while the other group (non-interventional) received conventional pharmaceutical care plan.

Enrollment: 50 patients

Sex: All

Ages: 18 to 80 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

Patients diagnosed with dyslipidemia and received at least one statin therapy (in the previous 6 months), and patients on the same class of pharmacological therapy (statins).

Exclusion criteria

1. Pregnant women
2. Nephrotic syndrome
3. Active steroid user
4. Hypersensitivity for any mediation during the trial
5. History of a major cardiovascular event in the previous 3 months
6. Patients with mental disease or disability
7. Had a stroke in the previous 6 months

Trial design

Primary purpose: Supportive Care

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: None (Open label)

---

50 participants in 2 patient groups

Non-intervention

No Intervention group

Description:

Patients received a conventional pharmaceutical care plan, the patients offered optimal pharmacological therapy wit statin.

Intervention

Active Comparator group

Description:

The Patients offered to predesign pharmaceutical care plans aimed to improved patient's knowledge, adherence, satisfaction, and quality of life. The patients offered optimal pharmacological therapy wit statin.

Treatment:

Behavioral: Pharmaceutical care plan